Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis
Acta Ophthalmologica Jun 15, 2018
Özdemir HB, et al. - Authors compared the antifungal effectiveness of corneal collagen cross-linking with photoactivated riboflavin (PACK-CXL) and voriconazole in experimental Fusarium solani and Candida albicans keratitis models. In the treatment groups vs the control groups, especially in groups that used PACK-CXL, fungus reproduction was less and the keratitis score was lower for Fusarium solani and Candida albicans. In the fungal keratitis algorithm combination of PACK-CXL treatment with medical treatment at the early stage of the disease was seen to be useful.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries